SCO & BRICS latest news and insights
— In-depth analysis and comments

By Rhod Mackenzie

India's attempt to "decouple" from China in the supply chain for active pharmaceutical ingredients (APIs) could lead to significant costs for the Indian and global pharmaceutical industry, this was cautioned by Chinese industry analysts. Such a move could impact the final market...